TCTAP 2024 Sponsors

Edwards Lifesciences Korea Co., Ltd.

Logo
  • Address: 36, Teheran-ro 87-gil, Gangnam-gu, Seoul, Republic of Korea
  • Website: www.edwards.com/kr
At Edwards Lifesciences, we are dedicated to providing innovative solutions for people fighting cardiovascular disease.
Through our actions, we will become trusted partners with customers, colleagues, and patients — creating a community unified in its mission to improve the quality of life around the world. Our results will benefit customers, patients, employees, and shareholders. We will celebrate our successes, thrive on discovery, and continually expand our boundaries. We will act boldly, decisively, and with determination on behalf of people fighting cardiovascular disease.
Helping patients is our life' work, and life is now.

Exhibition Item

SAPEIN 3 Ultra

Satellite Symposium

Lunchtime Activities

SAPIEN Planning for Safe TAVI Ensures Precise Protocols for Predictable Outcomes

Organized by CVRF and Supported by Educational Grant from Edwards Lifesciences Korea Co., Ltd.

Thursday, April 25
12:45 PM ~ 1:45 PM * KST (UTC/GMT +9:00)
Valve & Endovascular Theater, Level 2
12:45 PM Session Introduction
12:47 PM AMC CT Algorithm for TAVR with SAPIEN 3 Platform
Lecturer: Do-Yoon Kang
1:02 PM Case Presentation 1: Strategic Planning with CT to Ensures Accurate Outcome
Lecturer: Ronen Gurvitch
1:17 PM Case Presentation 2: Conquer Challenging Anatomies with SAPIEN 3 and Strategic Planning
Lecturer: James Flaherty
1:32 PM Discussion

Lunchtime Activities

SAPIEN : Simplifying Life Time Management for Present and Future

Organized by CVRF and Supported by Educational Grant from Edwards Lifesciences Korea Co., Ltd.

Saturday, April 27
12:45 PM ~ 1:45 PM * KST (UTC/GMT +9:00)
Valve & Endovascular Theater, Level 2
12:45 PM Session Introduction
12:47 PM SAPIEN 3 Platform Handles Complex TAVI Cases
Lecturer: Tae-Hyun Yang
1:02 PM New TAVI Trends Improve Lifetime Management
Lecturer: Karl Poon
1:17 PM Consolidate PARTNER 3 5-year Data; More Information Available
Lecturer: James Flaherty
1:32 PM Discussion